You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys AFP IVD Elecsys® AFP CPS_000431 AFP α1-fetoprotein 09731385190 AFP Elecsys E2G 100 V2 AFP Elecsys E2G 100 V2 07613336217146 Reagents, kits 100 tests cobas e 402/801 true 04491742160 AFP Elecsys cobas e 200 Elecsys AFP 04015630938810 Reagents, kits 200 tests cobas e 601/602 true 04481798190 AFP Elecsys cobas e 100 V1.1 Elecsys AFP 04015630920716 Reagents, kits 100 tests cobas e 411/601/602 true 09015060160 AFP Elecsys cobas e 100 V2 Elecsys AFP 07613336206157 Reagents, kits 100 tests cobas e 411/601/602 true 09015060190 AFP Elecsys cobas e 100 V2 Elecsys AFP 07613336172001 Reagents, kits 100 tests cobas e 411/601/602 true 09015124190 AFP Elecsys E2G 300 V2 Elecsys AFP 07613336172025 Reagents, kits 300 tests cobas e 402/801 true 04491742190 AFP Elecsys cobas e 200 Elecsys AFP 04015630920884 Reagents, kits 200 tests cobas e 601/602 true 07026706190 AFP Elecsys E2G 300 Elecsys AFP 04015630939909 Reagents, kits 300 tests cobas e 402/801 true 09015086160 AFP Elecsys cobas e 200 V2 Elecsys AFP 07613336206164 Reagents, kits 200 tests cobas e 601/602 undefined 09015086190 AFP Elecsys cobas e 200 V2 Elecsys AFP 07613336172018 Reagents, kits 200 tests cobas e 601/602 true 09731385501 Elecsys AFP en 1 FF0000000746B70E FF0000000746B70E 09731385190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma to aid in the management of patients with non‑seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09731385500 Elecsys AFP en 1 FF000000066E020E FF0000000656600E 09731385190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 04491742501 Elecsys AFP en 5 FF00000003EA1A0E FF0000000015670E 04491742160 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma to aid in the management of patients with non‑seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas eimmunoassay analyzers. en 04481798500 Elecsys AFP en 18 FF0000000633220E FF000000002B900E 04481798190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 04481798500 Elecsys AFP en 17 FF00000004C5890E FF0000000004290E 04481798190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 04481798501 Elecsys AFP en 9 FF000000041AE10E FF0000000042080E 04481798190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma to aid in the management of patients with non‑seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 09015060501 Elecsys AFP en 2 FF00000006CDFD0E FF00000005CFFF0E 09015060160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma to aid in the management of patients with non‑seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015060500 Elecsys AFP en 3 FF000000062EFD0E FF00000004BD520E 09015060190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015060500 Elecsys AFP en 1 FF00000004BD520E FF0000000489570E 09015060190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015124500 Elecsys AFP en 4 FF00000006F0E20E FF0000000488A60E 09015124190 09015124214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015124501 Elecsys AFP en 3 FF00000006AD9B0E FF00000005D93D0E 09015124190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma to aid in the management of patients with non‑seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015124500 Elecsys AFP en 3 FF000000062F020E FF0000000489CE0E 09015124190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 04491742500 Elecsys AFP en 10 FF0000000633280E FF0000000036820E 04491742190 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07026706500 Elecsys AFP en 4 FF00000003FB850E FF00000001891C0E 07026706190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07026706500 Elecsys AFP en 6 FF00000004C5E30E FF0000000438930E 07026706190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026706500 Elecsys AFP en 5 FF0000000438930E FF00000000EB550E 07026706190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026706501 Elecsys AFP en 2 FF00000003A5B30E FF00000001F24B0E 07026706190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma to aid in the management of patients with non‑seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015086501 Elecsys AFP en 2 FF00000006CE090E FF00000005D0190E 09015086160 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma to aid in the management of patients with non‑seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015086500 Elecsys AFP en 3 FF000000062F000E FF00000004BD530E 09015086190 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en
